Trust Co. of Vermont Sells 637 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Trust Co. of Vermont lowered its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 40,092 shares of the medical research company’s stock after selling 637 shares during the period. Trust Co. of Vermont’s holdings in Thermo Fisher Scientific were worth $11,774,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Ipswich Investment Management Co. Inc. raised its stake in Thermo Fisher Scientific by 0.5% during the second quarter. Ipswich Investment Management Co. Inc. now owns 7,773 shares of the medical research company’s stock worth $2,283,000 after buying an additional 35 shares during the last quarter. Van Hulzen Asset Management LLC raised its stake in Thermo Fisher Scientific by 3.1% during the first quarter. Van Hulzen Asset Management LLC now owns 1,197 shares of the medical research company’s stock worth $328,000 after buying an additional 36 shares during the last quarter. Valeo Financial Advisors LLC raised its stake in Thermo Fisher Scientific by 2.0% during the first quarter. Valeo Financial Advisors LLC now owns 1,911 shares of the medical research company’s stock worth $523,000 after buying an additional 38 shares during the last quarter. Community Bank & Trust Waco Texas raised its stake in Thermo Fisher Scientific by 1.8% during the first quarter. Community Bank & Trust Waco Texas now owns 2,366 shares of the medical research company’s stock worth $648,000 after buying an additional 42 shares during the last quarter. Finally, Intrust Bank NA raised its stake in Thermo Fisher Scientific by 1.0% during the first quarter. Intrust Bank NA now owns 4,213 shares of the medical research company’s stock worth $1,153,000 after buying an additional 42 shares during the last quarter. 88.02% of the stock is owned by hedge funds and other institutional investors.

In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total value of $670,725.00. Following the completion of the sale, the chief financial officer now directly owns 40,029 shares of the company’s stock, valued at $10,739,380.41. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the completion of the sale, the chief executive officer now directly owns 342,193 shares of the company’s stock, valued at $97,466,832.19. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 52,775 shares of company stock valued at $14,986,676. Insiders own 0.45% of the company’s stock.

TMO traded up $6.01 during midday trading on Tuesday, hitting $274.47. The company had a trading volume of 1,084,362 shares, compared to its average volume of 1,445,578. Thermo Fisher Scientific Inc. has a 52 week low of $208.34 and a 52 week high of $305.45. The company has a quick ratio of 1.07, a current ratio of 1.49 and a debt-to-equity ratio of 0.58. The stock has a market cap of $109.92 billion, a P/E ratio of 24.68, a price-to-earnings-growth ratio of 1.80 and a beta of 1.11. The stock’s 50 day simple moving average is $290.64.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share for the quarter, beating the consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The firm had revenue of $6.32 billion during the quarter, compared to the consensus estimate of $6.31 billion. During the same period in the previous year, the firm posted $2.75 earnings per share. The business’s revenue was up 3.9% compared to the same quarter last year. Sell-side analysts forecast that Thermo Fisher Scientific Inc. will post 12.23 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, September 17th will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.28%. The ex-dividend date is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 6.83%.

TMO has been the subject of a number of analyst reports. Bank of America reissued a “buy” rating and set a $300.00 target price (up previously from $285.00) on shares of Thermo Fisher Scientific in a research note on Tuesday, April 16th. Wolfe Research initiated coverage on shares of Thermo Fisher Scientific in a research note on Thursday, May 30th. They set an “outperform” rating for the company. Needham & Company LLC lifted their target price on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 target price for the company in a research note on Wednesday, June 12th. Finally, Argus lifted their target price on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $303.17.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Further Reading: Different Types of Derivatives

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.